Topic Archives: BioSig Technologies (BSGM)

Today I thought I’d take a look at the latest teaser pitch from Extreme Fortunes, a “no refunds” monthly stock-picking newsletter that they’re currently pricing at $2,995/yr., positioned as the “upgrade” letter from Paul Mampilly’s Profits Unlimited over at Banyan Hill and focused more, they indicate, on smaller-cap stocks. Mampilly, by the way, headlines no […]

Comments

  • Avatar

    Resverlogix has no ongoing clinical trial on the ClinicalTrials.gov site. Not sure what they are addressing. There are s...

  • Avatar

    For those considering Advaxis (ADXS) which Dr.KSS and Jean-Pierre Ruiz discussed earlier I found some non-scientific inf...

  • DrKSSMDPhD

    I appreciate JP Ruiz mining so much helpful information on Advaxis $ADXS. This company is a play on the immune stimul...

  • Avatar

    Advaxis (ADXS) is listed on the NASDAQ. It's 52-week range is $2.46 - $5.99 with average volume of 250,914 shares. Marke...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info